Cargando…
Correction to: A Review of Aflibercept Treatment for Macular Disease
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319275/ https://www.ncbi.nlm.nih.gov/pubmed/34213757 http://dx.doi.org/10.1007/s40123-021-00366-x |
| _version_ | 1783730412450742272 |
|---|---|
| author | Anguita, Rodrigo Tasiopoulou, Anastasia Shahid, Syed Roth, Janice Sim, Sing Yue Patel, Praveen J. |
| author_facet | Anguita, Rodrigo Tasiopoulou, Anastasia Shahid, Syed Roth, Janice Sim, Sing Yue Patel, Praveen J. |
| author_sort | Anguita, Rodrigo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8319275 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83192752021-08-02 Correction to: A Review of Aflibercept Treatment for Macular Disease Anguita, Rodrigo Tasiopoulou, Anastasia Shahid, Syed Roth, Janice Sim, Sing Yue Patel, Praveen J. Ophthalmol Ther Correction Springer Healthcare 2021-07-02 2021-09 /pmc/articles/PMC8319275/ /pubmed/34213757 http://dx.doi.org/10.1007/s40123-021-00366-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Anguita, Rodrigo Tasiopoulou, Anastasia Shahid, Syed Roth, Janice Sim, Sing Yue Patel, Praveen J. Correction to: A Review of Aflibercept Treatment for Macular Disease |
| title | Correction to: A Review of Aflibercept Treatment for Macular Disease |
| title_full | Correction to: A Review of Aflibercept Treatment for Macular Disease |
| title_fullStr | Correction to: A Review of Aflibercept Treatment for Macular Disease |
| title_full_unstemmed | Correction to: A Review of Aflibercept Treatment for Macular Disease |
| title_short | Correction to: A Review of Aflibercept Treatment for Macular Disease |
| title_sort | correction to: a review of aflibercept treatment for macular disease |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319275/ https://www.ncbi.nlm.nih.gov/pubmed/34213757 http://dx.doi.org/10.1007/s40123-021-00366-x |
| work_keys_str_mv | AT anguitarodrigo correctiontoareviewofaflibercepttreatmentformaculardisease AT tasiopoulouanastasia correctiontoareviewofaflibercepttreatmentformaculardisease AT shahidsyed correctiontoareviewofaflibercepttreatmentformaculardisease AT rothjanice correctiontoareviewofaflibercepttreatmentformaculardisease AT simsingyue correctiontoareviewofaflibercepttreatmentformaculardisease AT patelpraveenj correctiontoareviewofaflibercepttreatmentformaculardisease |